U.S. Markets closed

INmune Bio, Inc. (INMB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.71+0.43 (+3.24%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close13.28
Bid13.30 x 1200
Ask13.71 x 800
Day's Range13.41 - 14.43
52 Week Range8.40 - 30.37
Avg. Volume393,625
Market Cap204.726M
Beta (5Y Monthly)2.73
PE Ratio (TTM)N/A
EPS (TTM)-1.01
Earnings DateMay 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.75
  • GlobeNewswire

    CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors

    DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced the appointment of Dr. Ed Baracchini as chairman of the Company’s board of directors. “As a member of the CoImmune board of directors, Dr. Baracchini has provided strong counsel and guidance on many important issues in corporate development and strategy,” stated Dr. Charles Nicolette, chief exec

  • Simply Wall St.

    How Much Of INmune Bio, Inc. (NASDAQ:INMB) Do Insiders Own?

    If you want to know who really controls INmune Bio, Inc. ( NASDAQ:INMB ), then you'll have to look at the makeup of its...

  • Motley Fool

    INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript

    Image source: The Motley Fool. INmune Bio, Inc. (NASDAQ: INMB)Q3 2021 Earnings CallNov 03, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings, and welcome to the INmune Bio third quarter 2021 earnings call.